Corvus Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
/ 
Frequently asked questions
To buy Corvus Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Corvus Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Corvus Pharmaceuticals Inc. is CRVS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Corvus Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Corvus Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Corvus Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Corvus Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Corvus Pharmaceuticals Inc..